The purpose of this study is to find out whether injecting the U.S. Food and Drug Administration (FDA) approved drug EXPAREL®, a long acting (approximately 96 hours) numbing medication, will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE®.
Protocol Amendment History
5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-03-09; most recent amendment 2025-09-10.
Status change: Not Yet Recruiting → Recruiting2022-06-11